Emerging Treatment Approaches and Multidisciplinary Management of Unresectable Stage III Non-Small Cell Lung Cancer - Episode 7

Assessment and Management Strategies for Pneumonitis in Durvalumab Consolidation Post Chemoradiotherapy

This video discusses the clinical considerations around pneumonitis in patients undergoing chemoradiation and immunotherapy, including how to distinguish between radiation-induced and immune-related pneumonitis, and the importance of consulting specialists to avoid prematurely discontinuing treatment like durvalumab.

Video content above is prompted by the following:

  • How does the care team coordinate to manage pneumonitis?